Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Tumour Sites: Lung and other Thoracic Tumours

ESMO scientific and educational resources on this topic
Recent medwireNews, books and resources from conferences are for ESMO Members only.

Non-Small Cell Lung Cancer (NSCLC)

Find future ESMO Meetings

Check the future Preceptorship course on this topic

Practice tools

How to know when a re-biopsy is necessary for an advanced NSCLC patient?

ESMO Checklists

The organ-specific ESMO Checklists are a set of cancer patient management workflow templates for oncologists at the point of care. This hands-on self-assessment tool will help you easily check that the essential steps recommended in the ESMO Guidelines have been actually taken in your daily practice.

Download the ESMO Checklists

ESMO Webinars on-demand

Clinical Practice Guidelines

Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer Clinical Practice Guideline – Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer

24 Jan 2023

Non-Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer Clinical Practice Guideline – Non-Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer

17 Jan 2023

Malignant Pleural Mesothelioma Clinical Practice Guideline – Malignant Pleural Mesothelioma

30 Nov 2021

Small-Cell Lung Cancer Clinical Practice Guidelines – Small-Cell Lung Cancer

14 Apr 2021

PAGA for locally-advanced unresectable NSCLC (2019) Pan-Asian Adapted ESMO Clinical Practice Guidelines – Management of Patients with Locally-Advanced Unresectable NSCLC

06 Jan 2020

More guidelines

Latest ESMO videos

ESMO22 Expert report on neoadjuvant immune checkpoint inhibitors for NSCLC

21 Sep 2022

Read more

Highlights on first-line atezolizumab in patients with NSCLC not eligible for platinum: The IPSOS study

13 Sep 2022

Read more

Highlights on Sotorasib in NSCLC with KRAS G12C mutation: The CodeBreaK 200 study

12 Sep 2022

Read more

Highlights on actionable inflammatory axis for air pollution induced NSCLC

10 Sep 2022

Read more

Expert Video Report on featured outcomes from novel NSCLC trials - AACR 2022

25 Apr 2022

Read more

Watch all ESMO videos

Featured medwireNews

11 Aug 2022

Anticancer Agents; Immunotherapy; Small Cell Lung Cancer

Pembrolizumab–Etoposide Offers Long-Term ‘Clinically Meaningful Improvement’ In ES-SCLC Survival

10 Aug 2022

Immunotherapy; Non-Small Cell Lung Cancer

Nivolumab Addition To Adjuvant Chemotherapy Boosts Resectable Stage IIIA–B NSCLC Survival

09 Aug 2022

Immunotherapy; Non-Small Cell Lung Cancer

IMpower010 Interim OS Findings ‘Support’ Adjuvant Atezolizumab Benefit–Risk Profile

08 Jun 2022

Non-Small Cell Lung Cancer; Personalised/Precision Medicine

NRG1 Fusion-Positive Tumour Therapies Show Early Potential

04 Jun 2022

Anticancer Agents; Non-Small Cell Lung Cancer; Personalised/Precision Medicine

CHRYSALIS, CHRYSALIS-2 Updates Add Support For Amivantamab Use In Specific NSCLC Populations

More news

E-Learning

22 Dec 2022

Non-Small Cell Lung Cancer

ESMO E-Learning: Rare Oncogenic Alterations in NSCLC

David Planchard

12 Jul 2022

Non-Small Cell Lung Cancer

ESMO E-Learning: Important Pathways to Target in (Advanced) NSCLC: A Focus on EGFR-Inhibition and Implications for Clinical Practice

Floriana Morgillo , Morena Fasano

07 Jun 2022

Targeted Therapy; Non-Small Cell Lung Cancer

ESMO E-Learning: Diagnostic Work Up in NSCLC and the Importance of Optimal Tissue Management in the Era of Precision Medicine

Noemi Reguart , Cristina Teixido

19 May 2022

Non-Small Cell Lung Cancer

ESMO E-Learning: Important Pathways to Target in (Advanced) NSCLC: A Focus on ALK Inhibition in Non-Small-Cell Lung Cancer (NSCLC)

Floriana Morgillo , Morena Fasano

16 Mar 2022

Small Cell Lung Cancer

ESMO E-Learning: The Evolving Landscape of Extensive Stage Small Cell Lung Cancer

Andrea Ardizzoni , Giuseppe Lamberti

More e-learning modules

Factsheets on Biomarkers

25 Jan 2017

Non-Small Cell Lung Cancer

T790M in NSCLC: ESMO Biomarker Factsheet

Nicola Normanno

19 Apr 2016

Non-Small Cell Lung Cancer

ROS1 in Lung Cancer: ESMO Biomarker Factsheet

Keith Kerr

02 Aug 2015

Non-Small Cell Lung Cancer

ALK in Lung Cancer: ESMO Biomarker Factsheet

Keith Kerr

02 Aug 2015

Non-Small Cell Lung Cancer

EGFR in Lung Cancer: ESMO Biomarker Factsheet

More factsheets

Meeting resources

ESMO-ELCC-2023-1000x1000

ESMO Congress

European Lung Cancer Congress 2023

29 Mar 2023 Copenhagen

31 Mar 2023

16MO - Clinical impact of plasma EGFR analysis: results from the ETOP-BOOSTER randomized phase II trial

Presenter: Ross Soo

Session: Mini Oral 2

Resources:

Abstract

31 Mar 2023

15MO - Efficacy and ctDNA analysis in an updated cohort of patients with TRK fusion lung cancer treated with larotrectinib

Presenter: Martin Hoejgaard

Session: Mini Oral 2

Resources:

Abstract

31 Mar 2023

12MO - Patterns of response in metastatic (m) NSCLC after 2 and 4 cycles of chemotherapy (CT), alone or with durvalumab (D) ± tremelimumab (T), in the phase 3 POSEIDON study

Presenter: Niels Reinmuth

Session: Mini Oral 2

Resources:

Abstract

31 Mar 2023

13MO - Safety and efficacy of tusamitamab ravtansine in combination with pembrolizumab ± chemotherapy in patients with CEACAM5-positive nonsquamous NSCLC (CARMEN-LC05 phase 2 study)

Presenter: Luis Paz-Ares

Session: Mini Oral 2

Resources:

Abstract

More meeting resources